0001493152-23-043870.txt : 20231206 0001493152-23-043870.hdr.sgml : 20231206 20231206160538 ACCESSION NUMBER: 0001493152-23-043870 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231204 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RetinalGenix Technologies Inc. CENTRAL INDEX KEY: 0001836295 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 823936890 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-258528 FILM NUMBER: 231469654 BUSINESS ADDRESS: STREET 1: 1450 NORTH MCDOWELL BOULEVARD STREET 2: SUITE 150 CITY: PETALUMA STATE: CA ZIP: 94954 BUSINESS PHONE: 415-578-9583 MAIL ADDRESS: STREET 1: 1450 NORTH MCDOWELL BOULEVARD STREET 2: SUITE 150 CITY: PETALUMA STATE: CA ZIP: 94954 8-K 1 form8-k.htm
false 0001836295 0001836295 2023-12-04 2023-12-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) December 4, 2023

 

RETINALGENIX TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)

 

Delaware   333-258528   82-3936890

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

 

1450 North McDowell Boulevard, Suite 150

Petaluma, CA 94954

(Address of principal executive offices, including zip code)

 

(415) 578-9583

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 4, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Ms. Dessislava (Dessy) Boneva M.D. FACS, to serve as a director of the Company.

 

Dr. Boneva, age 52, is an experienced trauma surgeon skilled in trauma, surgical critical care, emergency surgery, and acute care surgery. She is in practice with Kendall Regional Medical Center in Miami, Florida. With two decades of experience, she is board-certified in surgery and surgical critical care by the American Board of Surgery (ABS). In her academic role, Dr. Boneva serves as Surgery Clerkship Director/Clinical Assistant Professor of Surgery at Nova Southeastern University’s Dr. Kiran C. Patel College of Allopathic Medicine. A Fellow of the American College of Surgeons (FACS), she is a member of the Society of Critical Care Medicine, the Panamerican Trauma Society, the Eastern Association for the Surgery of Trauma, and the American Association for the Surgery of Trauma. In addition, she holds certifications in Advanced Trauma Life Support (Instructor), Advanced Surgical Skills for Exposure in Trauma, Advanced Trauma Operative Management, Basic Life Support, and Pediatric Advanced Life Support.

 

Dr. Boneva performed her residencies in general surgery at the University of Maryland and Dartmouth College. This was followed by fellowship training at the Johns Hopkins University in Surgical Critical Care and the R Adams Cowley Shock Trauma Center in Trauma and Acute Care Surgery in 2010 and 2011, respectively.

 

There are no family relationships between Dr. Boneva and any of the Company’s directors or executive officers, nor does Dr. Boneva have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Other than as described above, there were no arrangements or understandings by which Dr. Boneva was appointed as a member of the Board.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibits are furnished with this Current Report on Form 8-K:

 

Exhibit

Number

  Exhibit Description
104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within in the inline XBRL document)

 

-2-

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  RETINALGENIX TECHNOLOGIES INC.
     
Date: December 6, 2023 By: /s/ Jerry Katzman
    Jerry Katzman
    Chief Executive Officer

 

-3-

EX-101.SCH 2 rtgn-20231204.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 rtgn-20231204_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 rtgn-20231204_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Dec. 04, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 04, 2023
Entity File Number 333-258528
Entity Registrant Name RETINALGENIX TECHNOLOGIES INC.
Entity Central Index Key 0001836295
Entity Tax Identification Number 82-3936890
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1450 North McDowell Boulevard
Entity Address, Address Line Two Suite 150
Entity Address, City or Town Petaluma
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94954
City Area Code (415)
Local Phone Number 578-9583
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
XML 6 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001836295 2023-12-04 2023-12-04 iso4217:USD shares iso4217:USD shares false 0001836295 8-K 2023-12-04 RETINALGENIX TECHNOLOGIES INC. DE 333-258528 82-3936890 1450 North McDowell Boulevard Suite 150 Petaluma CA 94954 (415) 578-9583 false false false false true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://retinalgenix.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm rtgn-20231204.xsd rtgn-20231204_lab.xml rtgn-20231204_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "RTGN", "nsuri": "http://retinalgenix.com/20231204", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "rtgn-20231204.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "rtgn-20231204_lab.xml" ] }, "presentationLink": { "local": [ "rtgn-20231204_pre.xml" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 21 }, "report": { "R1": { "role": "http://retinalgenix.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-12-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-04", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://retinalgenix.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001493152-23-043870-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-043870-xbrl.zip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end